Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms
The DOI matches its Crossref record; 257 of the 257 references it cites were found in a registry or an index.
Abstract
Increasing evidence demonstrates that neuroplasticity, a fundamental mechanism of neuronal adaptation, is disrupted in mood disorders and in animal models of stress. Here we provide an overview of the evidence that chronic stress, which can precipitate or exacerbate depression, disrupts neuroplasticity, while antidepressant treatment produces opposing effects and can enhance neuroplasticity. We discuss neuroplasticity at different levels: structural plasticity (such as plastic changes in spine and dendrite morphology as well as adult neurogenesis), functional synaptic plasticity, and the molecular and cellular mechanisms accompanying such changes. Together, these studies elucidate mechanisms that may contribute to the pathophysiology of depression. Greater appreciation of the convergence of mechanisms between stress, depression, and neuroplasticity is likely to lead to the identification of novel targets for more efficacious treatments.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“current evidence indicates that impairment in growth factor signaling is associated with depressed mood (Pittenger and Duman 2008).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Pittenger and Duman 2008
In the citing paper
“neurotrophic growth factors and related signaling pathways constitute major players in neuroplasticity”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Pittenger and Duman 2008
In the citing paper
“In addition, clean-cut evidence shows that antidepressants require neuroplasticity pathways to rescue the observed deficits in neuronal and synaptic plasticity often associated with mood disorders (Pittenger and Duman 2008).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Pittenger and Duman 2008
In the citing paper
“While traditional antidepressants acutely increase synaptic levels of monoamines, their chronic administration leads to changes in structural neuroplasticity that are contemporaneous with their clinical therapeutic effects (10–12).”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [10]
In the citing paper
“these changes in neural circuitry are believed to underlie the deficits in learning/memory, mood, motivation, and reward seeking that are characteristic of depression and related disorders (10, 67–74)”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [10]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120 · cited 1×
“The relationship between psychosocial stressors and the development of depression in susceptible individuals has long been apparent (Kendler et al, 1999; Caspi et al, 2003).”
BackgroundNeurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369
The Organization of Behavior; A Neuropsychological Theory.
Attneave, F., B., M., & Hebb, D. O. (1950) · The American Journal of Psychology · doi:10.2307/1418888 · Cited by 5,146
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 1×
“As neurogenesis appears to be required for the behavioral response to antidepressants in rodents (Santarelli et al, 2003; see below) and impaired neurogenesis has been hypothesized to represent a core pathophysiological feature of major depression (Duman, 2004), this effect represents yet another…”
BackgroundSelf-citationThe Organization of Behavior: A Neuropsychological Theory
(1950) · Journal of the American Medical Association · doi:10.1001/jama.1950.02910470083028 · Cited by 4,195
Malenka, R. C., & Bear, M. F. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.012 · Cited by 3,968
The molecular biology of memory storage: a dialogue between genes and synapses
Kandel, E. R. (2001) · Science · doi:10.1126/science.1067020 · Cited by 3,917 · cited 2×
“CREB, and other inducible transcription factors, induce effector genes that contribute to the stabilization of synaptic plasticity (Kandel, 2001).”
BackgroundEgan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Research works printed but not linked: 3
- American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders (DSM) IV-TR. American Psychiatric Press: Washington, DC.
- Nemeroff CB (2006). Use of atypical antipsychotics in refractory depression and anxiety. J Clin Psych 66 (S8): 13–21.
- O'Connor JJ, Rowan MJ, Anwyl R (1993). Naunyn Schmiedebergs Arch. Pharmacology 348: 158–163.
Cited by
Items 201–300 of 1,010
Efficacy markers in depression
Harmer, C. J., Cowen, P. J., & Goodwin, G. M. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110367722 · Cited by 122
“…interest in effects of antidepressants on hypothalamic–pituitary–adrenal (HPA) function, immune responsively, cellular plasticity, and neurogenesis (for example see Pariante and Lightman, 2008; Pittenger and Duman, 2008), all or any of which may contribute significantly to therapeutic actions.”
BackgroundChiu, C., Chyau, C.-C., Chen, C., Lee, L., Chen, W.-P., Liu, J.-L., Lin, W., & Mong, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020341 · Cited by 136
“Accumulating data suggest that stress plays an important role in the development and manifestation of depression [3,4], and restraint stress (RS) has been applied as a major promoter of depression-like condition to verify the effectiveness of antidepressant activities [33].”
BackgroundCzéh, B., Perez-Cruz, C., Fuchs, E., & Flügge, G. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.031 · Cited by 117
“Because experimental paradigms using chronic stress exposure have recently emerged as valuable animal models of mood disorders [61,121] we briefly summarize related human data on the involvement of prefrontal cortical areas in the regula-”
Social vs. environmental stress models of depression from a behavioural and neurochemical approach
Vénzala, E., Garcia‐García, Á. L., Elizalde, N., & Tordera, R. M. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.05.010 · Cited by 132
“…disorder since there is good evidence that both onset and relapse of depressive disorders can be precipitated by repeated stress or severe stressful experiences (Kessler, 1997; Kendler et al., 1999, 2001; Mazure et al., 2000; Monroe et al., 2006; Hammen, 2005; Pittenger and Duman, 2008).”
Mood-stabilizing drugs: mechanisms of action
Schloesser, R. J., Martinowich, K., & Manji, H. K. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.009 · Cited by 136
Mitochondria and the economy of stress (mal)adaptation
Morava, É., & Kozicz, T. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.02.005 · Cited by 128
Serum S100B Represents a New Biomarker for Mood Disorders
Schroeter, M., Sacher, J., Steiner, J., Schoenknecht, P., & Mueller, K. (2013) · Current Drug Targets · doi:10.2174/13894501113149990014 · Cited by 115
“Recently, it has been suggested that a loss of neuroplasticity and cellular resilience may underlie the pathophysiology of mood disorders and that effective long-term treatment can only be achieved by early neurotrophic and/or neuroprotective intervention [1, 2].”
Nordanskog, P., Larsson, M. R., Larsson, E. ‐., & Johanson, A. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12150 · Cited by 114
“Another, or simultaneous, mechanism of the volume decrease maybe the well-known link between hypercortisolaemia in stress and depression (2), causing structural changes in the hippocampus (45) and in gross structures in the brain (46).”
BackgroundGorzalka, B. B., & Hill, M. N. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.11.021 · Cited by 133
Consequences of sleep deprivation on neurotransmitter receptor expression and function
Longordo, F., Kopp, C., & Lüthi, A. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06719.x · Cited by 117
“Furthermore, a number of widely used SD procedures are accompanied by elevated stress levels which, by themselves, affect neuronal and synaptic function (Kim & Diamond, 2002; Pittenger & Duman, 2008).”
BackgroundA neural pathway controlling motivation to exert effort
Proulx, C. D., Aronson, S., Milivojevic, D., Molina, C., Loi, A., Monk, B., Shabel, S. J., & Malinow, R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801837115 · Cited by 119
Song, C., Liu, B.-P., Zhang, Y., Peng, Z., Wang, J., Collier, A. D., Echevarria, D. J., Savelieva, K. V., Lawrence, R. F., Rex, C. S., et al. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.08.021 · Cited by 125
“On the other hand, since rodent and clinical evidence strongly implicates chronic stress in pathologically reduced neuroplasticity (Pittenger and Duman, 2008), such opposite effects can also be possible in stressed fish.”
Dell’Osso, B., Glick, I. D., Baldwin, D. S., & Altamura, A. C. (2013) · Psychopathology · doi:10.1159/000338608 · Cited by 118
Green tea consumption is associated with depressive symptoms in the elderly
Niu, K., Hozawa, A., Kuriyama, S., Ebihara, S., Guo, H., Nakaya, N., Ohmori‐Matsuda, K., Takahashi, H., Masamune, Y., Asada, M., et al. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28216 · Cited by 130
“Stress is particularly well established as a factor that can cause depressive symptoms or contribute to the severity of depression (3).”
BackgroundStress, glucocorticoids and glutamate release: Effects of antidepressant drugs
Musazzi, L., Racagni, G., & Popoli, M. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.05.002 · Cited by 131
“Overall, the hypothesis of neuroplasticity proposes that abnormal increase of excitatory amino acid transmission induced by stress in select areas of the forebrain has a crucial role in the induction of morphological/functional changes associated with major depression (Pittenger and Duman, 2008; Racagni and Popoli, 20…”
Influential5-HT Receptors and the Development of New Antidepressants
Ślifirski, G., Król, M., & Turło, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22169015 · Cited by 126
Sun, Y., Zhang, H., Wu, Z., Yu, X., Yin, Y., Qian, S., Wang, Z., Huang, J., Wang, W., Liu, T., et al. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00371 · Cited by 126
Potential roles of zinc in the pathophysiology and treatment of major depressive disorder
Swardfager, W., Herrmann, N., McIntyre, R. S., Mazereeuw, G., Goldberger, K., Cha, D. S., Schwartz, Y., & Lanctôt, K. L. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.03.018 · Cited by 116
Kong, H., Sha, L.-L., Fan, Y., Xiao, M., Ding, J.-H., Wu, J., & Hu, G. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.185 · Cited by 115
Aleksandrova, L. R., Wang, Y. T., & Phillips, A. G. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.07.007 · Cited by 114
Open questions in current models of antidepressant action
Tanti, A., & Belzung, C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00585.x · Cited by 109
“Stress also blocks the induction of LTP at the projection from the amygdala to the PFC (Maroun and Richter-Levin, British Journal of Pharmacology (2010) 159 1187–1200 2003), and at the reverse projection, from PFC to amygdala, stress induces the promotion of LTP and inhibition of LTD (Maroun, 2006).”
BackgroundInfluentialMalatyńska, E., Steinbusch, H. W. M., Redkozubova, O. M., Bolkunov, A., Kubatiev, A. A., Yeritsyan, N., Vignisse, J., Бачурин, С. О., & Strekalova, T. V. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.04.010 · Cited by 121
“The role of these factors in the neurobiology of depression was generally documented (Skolnick et al., 2009; Pittenger and Duman, 2008; Marcocci et al., 2002), however, it remains to be studiedwhether dimebonmay exert any systemic effects via these mechanisms (Bachurin, 2003).”
Long-term effects of early life stress exposure: Role of epigenetic mechanisms
Silberman, D. M., Acosta, G. B., & Zubilete, M. A. Z. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2015.12.033 · Cited by 127
Neurohormonal and inflammatory hyper-responsiveness to acute mental stress in depression.
Weinstein, A. A., Deuster, P. A., Francis, J. L., Bonsall, R. W., Tracy, R. P., & Kop, W. J. (2010) · Biological Psychology · doi:10.1016/j.biopsycho.2010.01.016 · Cited by 113
“In addition, critical brain structure involvement may be the same in depression and acute stress, including the locus coeruleus and the central nucleus of the amygdala, which are both innervated by CRF-containing nerve terminals (Pittenger & Duman, 2008).”
BackgroundDifferential effects of antidepressant drugs on mTOR signalling in rat hippocampal neurons
Park, S. W., Lee, J. G., Seo, M. K., Lee, C. H., Cho, H. Y., Lee, B. J., Seol, W., & Kim, Y. H. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000534 · Cited by 111
“Different classes of antidepressant drugs, including SSRIs, TCAs, SNRIs and MOAIs, increase BDNF expression in the hippocampus (Pittenger and Duman, 2008).”
BackgroundInfluentialMarkham, A., Bains, R., Franklin, P., & Spedding, M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12531 · Cited by 111
“The interplay reflects a deep physiological role whereby inflammatory cytokines block trophic effects in sickness and perhaps depression (Koo and Duman, 2008; Pittenger and Duman, 2008; Spedding and Gressens, 2008; Markham et al., 2012).”
BackgroundGiacobbe, P., Mayberg, H. S., & Lozano, A. M. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.04.028 · Cited by 112
Stressful Events During Pregnancy and Postpartum Depressive Symptoms
Stone, S. L., Diop, H., Declercq, E., Cabral, H. J., Fox, M. P., & Wise, L. A. (2015) · Journal of Women's Health · doi:10.1089/jwh.2014.4857 · Cited by 112
“involved in memory and concentration.(54) Furthermore, prolonged stress can increase amygdala activity, affecting mood, and has been associated with elevated corticotrophin releasing hormones and elevated cortisol and corticosteroid levels.”
BackgroundEmerging Roles of CREB-Regulated Transcription Coactivators in Brain Physiology and Pathology
Saura, C. A., & Cardinaux, J. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.10.002 · Cited by 119
Tang, M., Huang, H., Li, S., Zhou, M., Liu, Z., Huang, R., Liao, W., Xie, P., & Zhou, J. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0605-4 · Cited by 118
Xue, K., Liang, S., Yang, B., Zhu, D., Xie, Y., Qin, W., Liu, F., Zhang, Y., & Yu, C. (2020) · Psychological Medicine · doi:10.1017/s0033291720003876 · Cited by 121
Transcranial direct current stimulation: A new tool for the treatment of depression?
Arul-Anandam, A. P., & Loo, C. K. A. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.01.016 · Cited by 120
Ruggiero, R. N., Rossignoli, M. T., Marques, D. B., de Sousa, B. M., Romcy-Pereira, R. N., Lopes-Aguiar, C., & Leite, J. P. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.732360 · Cited by 111
Morales-Medina, J. C., Sanchez, F., Flores, G., Dumont, Y., & Quirion, R. (2009) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2009.05.009 · Cited by 111
“Morphological changes are known to be correlated with alterations in neurotransmission (Fiala et al., 2002; Pittenger and Duman, 2008), for example a dendritic surface receives more than 95% of synapses of a given neuron (Kolb et al.”
BackgroundThe Effects of Acute Aerobic Exercise on the Primary Motor Cortex
Singh, A. M., & Staines, W. R. (2015) · Journal of Motor Behavior · doi:10.1080/00222895.2014.983450 · Cited by 99
“In the motor cortex, pharmacological blockade of NE receptors suppresses the induction of LTP-like plasticity (Korchounov & Ziemann, 2011) and conversely, the NE reuptake inhibitor reboxetine enhances M1 excitability (Herwig, Br€auer, Connemann, Spitzer, & Sch€onfeldtLecuona, 2002).”
BackgroundInfluentialA review of current evidence for acetyl-l-carnitine in the treatment of depression
Wang, S.-M., Han, C., Lee, S.-J., Patkar, A. A., Masand, P. S., & Pae, C.-U. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.02.005 · Cited by 110
Progressive alterations of hippocampal CA3-CA1 synapses in an animal model of depression
Qiao, H., An, S.-C., Ren, W., & Ma, X. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.08.040 · Cited by 115
Rodent models of social stress and neuronal plasticity: Relevance to depressive-like disorders
Patel, D., Kas, M. J., Chattarji, S., & Buwalda, B. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.111900 · Cited by 105
“These structural alterations range from total volumetric changes of speci fi c brain areas that control emotion, mood and cognitive functions to changes at a cellular level [7 – 10].”
BackgroundAthira, K. V., Bandopadhyay, S., Samudrala, P. K., Naidu, V. G. M., Lahkar, M., & Chakravarty, S. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191001142934 · Cited by 119
Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders
Bhat, A., Ray, B., Mahalakshmi, A. M., Tuladhar, S., Nandakumar, D., Srinivasan, M., Essa, M. M., Chidambaram, S. B., Guillemin, G. J., & Sakharkar, M. K. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105078 · Cited by 113
Allen, P. J., D'Anci, K. E., Kanarek, R. B., & Renshaw, P. F. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.160 · Cited by 95
“Stress has been studied extensively as a precipitating factor in the onset of depression (Caspi et al, 2003; Duman and Monteggia, 2006; Pittenger and Duman, 2008; Sapolsky, 2000), and the effects of a given treatment may vary greatly depending on whether the subject has a ‘healthy’ vs ‘depressed’ brain, the latter of…”
Seo, M. K., Ly, N. N., Lee, C. H., Cho, H. Y., Choi, C. M., Nhu, L. H., Lee, J. G., Lee, B. J., Kim, G.-M., Yoon, B. J., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.02.009 · Cited by 116
“Increased BDNF mRNA expression after antidepressant drug treatment is central to the BDNF hypothesis regarding antidepressant action (Pittenger and Duman, 2008).”
Stress-Induced Changes of Hippocampal NMDA Receptors: Modulation by Duloxetine Treatment
Calabrese, F., Guidotti, G., Molteni, R., Racagni, G., Mancini, M., & Riva, M. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037916 · Cited by 107
“It is feasible to hypothesize that, although the effects of classical antidepressants and of ketamine (or glutamate NMDA receptor antagonists) may converge on the same target, the modulation following prolonged exposure to antidepressants is probably part of a complex array of neuroadaptive changes produced by pharmac…”
Hippocampal GABAergic dysfunction in a rat chronic mild stress model of depression
Holm, M. M., Nieto‐Gonzalez, J. L., Vardya, I., Henningsen, K., Jayatissa, M. N., Wiborg, O., & Jensen, K. (2011) · Hippocampus · doi:10.1002/hipo.20758 · Cited by 107
Leuner, B., Fredericks, P. J., Nealer, C., & Albin-Brooks, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089912 · Cited by 99
“Another factor that could contribute to the adverse outcomes associated with gestational stress is glutamate [59–62].”
Backgroundl-Acetylcarnitine: A Mechanistically Distinctive and Potentially Rapid-Acting Antidepressant Drug
Chiechio, S., Canonico, P., & Grilli, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms19010011 · Cited by 104
“In addition, several experimental studies demonstrate that antidepressants can counteract the inhibitory effect of stress on ahNG in rodent models of depressive-like disorder [70,71].”
BackgroundTian, P., Zou, R., Song, L., Zhang, X., Jiang, B., Wang, G., Lee, Y. K., Zhao, J., Zhang, H., & Chen, W. (2019) · Food & Function · doi:10.1039/c9fo01630a · Cited by 113
Interplay between pro-inflammatory cytokines and growth factors in depressive illnesses
Audet, M.-C., & Anisman, H. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00068 · Cited by 104
“associated with the emergence of neuroaffective and neurocognitive symptoms, including those related to depressive illnesses (Kempermann and Kronenberg, 2003; Pittenger and Duman, 2008).”
BackgroundCentral role of glucocorticoid receptors in Alzheimer's disease and depression
Canet, G., Chevallier, N., Zussy, C., Desrumaux, C., & Givalois, L. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00739 · Cited by 106
Zanos, P., Nelson, M. E., Highland, J. N., Krimmel, S. R., Georgiou, P., Gould, T. D., & Thompson, S. M. (2017) · eNeuro · doi:10.1523/eneuro.0285-16.2017 · Cited by 106
Prins, J., Olivier, B., & Korte, S. M. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.594039 · Cited by 97
“Therefore, to fully understand the pathophysiology of major depression, one has to measure stress- and depression-related changes in in vivo neurotransmitter reuptake or release; (hetero) receptor trafficking, expression and functioning; post-receptor signaling cascades, gene transcription, translation and expression…”
BackgroundIñiguez, S. D., Aubry, A., Riggs, L. M., Alipio, J. B., Zanca, R. M., Flores-Ramirez, F. J., Hernandez, M. A., Nieto, S. J., Musheyev, D., & Serrano, P. A. (2016) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.07.001 · Cited by 105
“Thus, the cortical-related dopamine frequency signals to the hippocampus may be important for the expression of cognitive deficits that are associated with stress-induced illnesses like depression (Pittenger and Duman, 2008).”
BackgroundChen, F., Madsen, T. M., Wegener, G., & Nyengaard, J. R. (2010) · Hippocampus · doi:10.1002/hipo.20718 · Cited by 103
Neuroplasticity and major depression, the role of modern antidepressant drugs
Serafini, G. (2012) · World Journal of Psychiatry · doi:10.5498/wjp.v2.i3.49 · Cited by 103
Stress and glucocorticoid footprints in the brain—The path from depression to Alzheimer's disease
Sotiropoulos, I., Cerqueira, J. J., Catania, C., Takashima, A., Sousa, N., & Almeida, O. F. X. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.05.007 · Cited by 100
Cognitive deficits in the remitted state of unipolar depressive disorder.
Hasselbalch, B. J., Knorr, U., Hasselbalch, S. G., Gade, A., & Kessing, L. V. (2012) · Neuropsychology · doi:10.1037/a0029301 · Cited by 98
Kuo, H.-I., Paulus, W., Batsikadze, G., Jamil, A., Kuo, M., & Nitsche, M. A. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.270 · Cited by 118
Zhang, Y., Wang, Y., Wang, L., Bai, M., Zhang, X., & Zhu, X. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv025 · Cited by 104
“There is compelling evidence suggesting that both the onset and relapse of depression are associated with environmental stresses (Monroe et al., 2006; Pittenger and Duman, 2007).”
BackgroundSon, H., Banasr, M., Choi, M., Chae, S. Y., Licznerski, P., Lee, B., Voleti, B., Li, N., Lepack, A., Fournier, N. M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201191109 · Cited by 103
“Lenti-shNrn did not influence LMA (P = 0.16, Student t test).”
BackgroundMethodInfluentialSelf-citationInvolvement of BDNF in age-dependent alterations in the hippocampus
von Bohlen und Halbach, O. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00036 · Cited by 101
“…by reductions in dendritic arborization (Lucassen et al., 2006) and in the spine densities within the hippocampus and that treatment with antidepressants can ameliorate or reverse these reductions in spine densities (Norrholm and Ouimet, 2001; Pittenger and Duman, 2008; Hajszan et al., 2009).”
Krugers (2010) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2010.00024 · Cited by 102
“The normalizing effect has been most extensively studied with respect to neurogenesis (Czeh et al., 2001; Santarelli et al., 2003; Drew and Hen, 2007; Pittenger and Duman, 2008; Lucassen et al., 2010a).”
Csabai, D., Wiborg, O., & Czéh, B. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00024 · Cited by 101
“Recent theories emphasize the importance of disturbed neuroplasticity in the pathophysiology of depressive disorders (e.g., Pittenger and Duman, 2008; Castrén, 2013).”
BackgroundTraditional Chinese Medicine in Depression Treatment: From Molecules to Systems
Li, C., Huang, J., Cheng, Y., & Zhang, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00586 · Cited by 112
“The pathophysiological systems in the CNS that herbal antidepressants are proposed to act on include monoamine neurotransmissions, the HPA axis, neurotrophins, and synapse number and function as shown.”
BackgroundInfluentialGoto, T., Kubota, Y., Tanaka, Y., Iio, W., Moriya, N., & Toyoda, A. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.05.040 · Cited by 109
Chen, W., Lai, Y.-S., Lin, S.-H., Lu, K., Lin, Y., Panyod, S., Ho, C., & Sheen, L. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.02.001 · Cited by 105
“MDD strongly correlates with suicide attempts (Chen and Dilsaver, 1996; Placidi et al., 2001), and the World Health Organization predicts that MDD will result in the highest global disease burden by 2030 (Mathers et al., 2008).”
BackgroundInfluentialExploiting Circulating MicroRNAs as Biomarkers in Psychiatric Disorders
Roy, B., Yoshino, Y., Allen, L., Prall, K., Schell, G., & Dwivedi, Y. (2020) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-020-00464-9 · Cited by 95
Large-Scale Transcriptomics Studies Provide Insight Into Sex Differences in Depression
Seney, M. L., Glausier, J., & Sibille, E. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.12.025 · Cited by 95
“Chronic stress in male rodents recapitulates the dendritic pathology observed in MDD (75,76), and it is hypothesized that dendritic spine alterations contribute to MDD symptoms (77,78).”
BackgroundGörgülü, Y., & Çalıyurt, O. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.06.016 · Cited by 111
Epigenetics and depressive disorders: a review of current progress and future directions
Januar, V., Saffery, R., & Ryan, J. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyu273 · Cited by 99
MAPK signaling correlates with the antidepressant effects of ketamine
Réus, G. Z., Vieira, F. G., Abelaira, H. M., Michels, M., Tomaz, D. B., dos Santos, M. A. B., Carlessi, A. S., Neotti, M. V., Matias, B. I., da Luz, J. R., et al. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.04.010 · Cited by 104
Cantone, M., Bramanti, A., Lanza, G., Pennisi, M., Bramanti, P., Pennisi, G., & Bella, R. (2017) · ASN NEURO · doi:10.1177/1759091417711512 · Cited by 106
“These data further support the concept that dysfunctional neuroplasticity contributes to both mood and cognitive disorders (Pittenger and Duman, 2008; Krishnan and Nestler, 2008; Li et al., 2010; Dumas, 2012).”
BackgroundMicroRNAs in Mental Health: From Biological Underpinnings to Potential Therapies
Hunsberger, J. G., Austin, D. R., Chen, G., & Manji, H. K. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8070-5 · Cited by 98
“…several emerging themes associated with the biological underpinnings of psychiatric illnesses, including fundamental impairments in neuroplasticity (Pittenger and Duman 2008), increased neuronal vulnerability to aberrant stimuli (Kato 2008), and dysregulation in neurotrophic factor signaling…”
Markham, A., Cameron, I., Bains, R., Franklin, P., Kiss, J. P., Schwendimann, L., Gressens, P., & Spedding, M. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07965.x · Cited by 97
Pehrson, A. L., Leiser, S. C., Gulinello, M., Dale, E., Li, Y., Waller, J. A., & Sanchez, C. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.044 · Cited by 91
Mouillet‐Richard, S., Baudry, A., Launay, J., & Kellermann, O. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.035 · Cited by 99
“Impaired hippocampal neurogenesis seems to represent a core pathological feature of major depression (Duman, 2004; Macqueen and Frodl, 2010; Pittenger and Duman, 2008), although the “neurogenesis hypothesis of depression” is currently under debate (Hanson et al., 2011).”
BackgroundInfluentialFreudenberg, F., Celikel, T., & Reif, A. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.03.005 · Cited by 105
Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?
Kočárová, R., Horáček, J., & Carhart-Harris, R. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.661233 · Cited by 96
Helmich, I. (2010) · Clinical Practice & Epidemiology in Mental Health · doi:10.2174/1745017901006010115 · Cited by 86
“The ‘monoamine hypothesis’ of depression, which postulates that depression is caused by decreased monoamine function, especially serotonin (5-hydroxytryptamine 5-HT) and norepinephrine (NE) in the brain, originated from early clinical observations [41, 65].”
BackgroundInfluentialJeanneteau, F., Barrère, C., Vos, M., De Vries, C. J. M., Rouillard, C., Levesque, D., Dromard, Y., Moisan, M.-P., Duric, V., Franklin, T. C., et al. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.2793-17.2017 · Cited by 91
“Chronic stress impacts neuronal plasticity throughout the brain in part through excessive levels of glutamate and corticosterone (CORT) secretion that remodel dendritic territories in a manner that alters their functional properties (Pittenger and Duman, 2008; Popoli et al., 2011; Myers et al., 2014).”
Self-citationMariani, N., Cattane, N., Pariante, C. M., & Cattaneo, A. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01469-6 · Cited by 111
Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders
Lee, B.-H., & Kim, Y. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.07.021 · Cited by 105
“The neurotrophic hypothesis suggests that mood disorders are associatedwith dysfunction of neuronal networks (Pittenger and Duman, 2008).”
BackgroundPositive therapeutic and neurotropic effects of yoga in depression: A comparative study
Thirthalli, J., Naveen, G., Rao, M., Varambally, S., Christopher, R., & Gangadhar, B. (2013) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.116313 · Cited by 92
“[14] For less severe depression, antidepressant therapy or psychotherapy or complementary and alternative”
Brand, S., Moller, M., & Harvey, B. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150307004545 · Cited by 95
“BDNF regulates synaptic plasticity in neuronal networks and appears to be a particularly relevant factor for mood disorders with associated cognitive dysfunction [271-273].”
BackgroundBravo, J. A., Díaz-Veliz, G., Mora, S., Ulloa, J. L., Berthoud, V. M., Morales, P., Arancibia, S., & Fiedler, J. L. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32832c70d9 · Cited by 94
“, 2007), and neuropathology (Manji and Duman, 2001; Pittenger and Duman, 2008).”
BackgroundKim, Y., Amidfar, M., & Won, E. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.06.008 · Cited by 102
Amidfar, M., Woelfer, M., Réus, G. Z., Quevedo, J., Walter, M., & Kim, Y.-K. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109668 · Cited by 90
Chronic Stress and Headaches: The Role of the HPA Axis and Autonomic Nervous System
Sič, A., Bogicevic, M., Brezić, N., Nemr, C., & Knežević, N. N. (2025) · Biomedicines · doi:10.3390/biomedicines13020463 · Cited by 120
“Excess glucocorticoid exposure sensitizes the pain-processing networks within the trigeminal system and alters descending pain control pathways from the brainstem to the spinal trigeminal nucleus [39]. hippocampus further contribute to the development of chronic pain [60,61].”
Multiplex quantitative assays indicate a need for reevaluating reported small-molecule TrkB agonists
Boltaev, U., Meyer, Y., Tolibzoda, F., Jacques, T., Gassaway, M., Xu, Q., Wagner, F., Zhang, Y.-L., Palmer, M., Holson, E., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aal1670 · Cited by 94
Magnetic resonance imaging and prediction of outcome in patients with major depressive disorder
MacQueen, G. M. (2009) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0945 · Cited by 84
“Treatment with antidepressant medications may normalize abnormalities in corticolimbic function.3,4 Preclinical studies provide further evidence of structural changes in corticolimbic structures with stress that may be normalized with treatments for MDD.5 There is a paucity of studies, however, using within-subject pr…”
InfluentialHutchinson, K. M., McLaughlin, K. J., Wright, R. L., Bryce Ortiz, J., Anouti, D. P., Mika, A., Diamond, D. M., & Conrad, C. D. (2012) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2012.01.003 · Cited by 91
“…that depressed individuals express similar alterations in the hippocampus that can also be reversed by antidepressants helped inspire a novel hypothesis that depression and chronic stress hinder neuroplasticity and function similarly, especially within the hippocampus (Pittenger & Duman, 2008).”
BackgroundRisks of using SSRI / SNRI antidepressants during pregnancy and lactation
Dubovický, M., Belovičová, K., Csatlósová, K., & Bögi, E. (2017) · Interdisciplinary Toxicology · doi:10.1515/intox-2017-0004 · Cited by 106
“Thorne et al. (2000) reported that antidepressant therapy enhanced the phosphorylation of CREB and CRE-mediated gene expression in limbic regions of the brain.”
BackgroundInfluentialGregorio, D. D., Inserra, A., Enns, J. P., Markopoulos, A., Pileggi, M., Rahimy, Y. E., López-Canul, M., Comai, S., & Gobbi, G. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01301-9 · Cited by 101
“Chronic stress in rodents produces a decline of 5-HT firing activity [18], in addition to the development of anxiety-like phenotypes [19, 20].”
BackgroundFrye, C. A., & Walf, A. A. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.02.022 · Cited by 93
“Steroid hormones can clearly have trophic effects, which may underlie their effects to increase neuroplasticity, changes of which have been associated with depression and its treatment [36], [37], and [38].”
Disorders of memory and plasticity in psychiatric disease
Pittenger, C. (2013) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2013.15.4/cpittenger · Cited by 92
“Over the past 20 years, a startling parallel has emerged between the mechanisms implicated in various forms of neuroplasticity—synaptic plasticity, neuronal remodeling, and neurogenesis—and those implicated in stress-associated neuropsychiatric conditions, such as MDD.(3) The parallels, on multiple levels of analysis,…”
BackgroundInfluentialSelf-citationACF chromatin-remodeling complex mediates stress-induced depressive-like behavior
Sun, H., Damez-Werno, D. M., Scobie, K. N., Shao, N.-Y., Dias, C., Rabkin, J., Koo, J. W., Korb, E., Bagot, R. C., Ahn, F. H., et al. (2015) · Nature Medicine · doi:10.1038/nm.3939 · Cited by 91
Réus, G. Z., Manosso, L. M., Quevedo, J., & Carvalho, A. F. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105425 · Cited by 103
Segi-Nishida, E. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00142 · Cited by 86
“…sending afferents to the hippocampus, one of the stress-sensitive limbic structures implicated in the pathophysiology of Frontiers in Cellular Neuroscience | www.frontiersin.org 1 May 2017 | Volume 11 | Article 142 mood and anxiety disorders (Pittenger and Duman, 2008; Kheirbek et al., 2012).”
BackgroundHellewell, S. C., Beaton, C. S., Welton, T., & Grieve, S. M. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00350 · Cited by 90
New insights on neurobiological mechanisms underlying alcohol addiction
Cui, C., Noronha, A., Morikawa, H., Alvarez, V. A., Stuber, G. D., Szumlinski, K. K., Kash, T. L., Roberto, M., & Wilcox, M. V. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.09.022 · Cited by 86
“Similarly, significant lines of evidence indicate that the CRF signaling is also an important mediator for spine remodeling associated with stress (Chen et al., 2008; Pittenger and Duman, 2008; Radley et al., 2008; Shansky et al., 2009; Treweek et al., 2009).”
BackgroundPilar-Cuéllar, F., Vidal, R., Díaz, A., Castro, E., dos Anjos, S., Pascual-Brazo, J., Linge, R., Vargas, V., Blanco, H., Martínez-Villayandre, B., et al. (2013) · Neural Plasticity · doi:10.1155/2013/537265 · Cited by 90
Metadata
- Authors
- Pittenger, C., & Duman, R. S.
- Affiliations
- Yale University (US)
- Corresponding author
- Duman, Ronald S
- Venue
- Neuropsychopharmacology
- Published
- 2007-09-12
- Volume
- 33
- Issue
- 1
- Pages
- 88-109
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1978891587
- Cited by
- 1,795
- References
- 257
- Citations by year
- 2026: 48 · 2025: 77 · 2024: 83 · 2023: 73 · 2022: 98 · 2021: 137 · 2020: 107 · 2019: 95 · 2018: 97 · 2017: 105 · 2016: 97 · 2015: 99 · 2014: 112 · 2013: 108 · 2012: 147
- FWCI
- 6.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- chronic stress, depression, neuroplasticity, antidepressants, structural plasticity, adult neurogenesis, synaptic plasticity, dendritic spine morphology, mood disorders, animal models of stress, depression pathophysiology
- MeSH terms
- Animals, Depression, Humans, Learning Disabilities, Memory Disorders, Models, Neurological, Neuronal Plasticity, Neurons, Stress, Physiological, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.